Discharge Summary – Post–Living Donor Kidney Transplant

Admit Date: 06/03/2025
Discharge Date: 06/09/2025

Hospital Course:
Ms. Jamie Castillo is a 44-year-old woman with ESRD due to ADPKD admitted for scheduled living donor kidney transplant from her sister. Surgery uneventful, brisk urine output post reperfusion. She had stable recovery in ICU then transferred to floor. Pain controlled with oral medications. Renal function steadily improved (Cr 6.2 pre-op → 1.8 at discharge). Tacrolimus initiated POD#1, levels therapeutic. No infectious complications. Doppler ultrasounds POD#1 and POD#3 normal. Foley catheter removed POD#2 with spontaneous voiding. She ambulated independently by POD#4.

Discharge Medications:
- Tacrolimus 3 mg BID
- MMF 1 g BID
- Prednisone 20 mg daily
- Valganciclovir 450 mg daily
- TMP-SMX SS daily
- Magnesium oxide 400 mg daily
- Amlodipine 10 mg daily
- Labetalol 200 mg BID

Follow-Up:
- Transplant clinic in 4 days.
- Weekly labs including tacrolimus trough.
- Stent removal planned at ~5 weeks.

Condition on Discharge: Stable, good graft function.
